ZebraSci

ZebraSci is a specialized service provider in the combination product development sector, offering critical testing and consulting to de-risk and accelerate the pathway to market for injectable drug-delivery systems. Its core expertise lies in analytical services like Container Closure Integrity (CCI), silicone oil distribution analysis, and extractables & leachables studies, supported by proprietary inspection equipment and GMP/ISO-compliant labs. Acquired by BD, the company leverages this relationship while maintaining the agility to service non-BD devices, positioning itself as a key partner for pharma and biotech companies navigating complex regulatory and technical challenges.

Integrated suite of proprietary and standard analytical testing services for drug-device combination products, including specialized inspection systems for silicone oil distribution, container closure integrity (CCI) testing, and extractables & leachables (E&L) studies.

ZebraSci competes with large, full-service Contract Research Organizations (CROs) and specialized analytical testing labs in the niche combination product space. Its differentiation lies in its deep technical focus on specific high-stakes problems (e.g., silicone oil analysis), its proprietary equipment, and its unique position as an independent yet BD-backed service provider.